
Viemed Healthcare VMD
$ 8.95
1.13%
Quarterly report 2025-Q3
added 11-05-2025
Viemed Healthcare EV - Enterprise Value 2011-2026 | VMD
Annual EV - Enterprise Value Viemed Healthcare
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 386 M | 355 M | 178 M | 328 M | 231 M | 8.08 M | 13.9 M | 11.8 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 386 M | 8.08 M | 189 M |
EV - Enterprise Value of other stocks in the Medical devices industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aziyo Biologics
AZYO
|
89.6 M | - | 1.37 % | $ 20.5 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
76.6 M | - | - | $ 1.77 B | ||
|
Conformis
CFMS
|
3.84 M | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
3.81 B | $ 39.27 | -1.36 % | $ 5.85 K | ||
|
Lianluo Smart Limited
LLIT
|
655 M | - | 24.59 % | $ 44.8 M | ||
|
Cardiovascular Systems
CSII
|
595 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
421 M | - | -10.19 % | $ 1.99 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-5.83 M | - | -5.86 % | $ 30.6 M | ||
|
Acutus Medical
AFIB
|
40.9 M | - | -26.83 % | $ 2.62 M | ||
|
Dynatronics Corporation
DYNT
|
13.8 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-53 M | - | - | $ 10.2 M | ||
|
Cognyte Software Ltd.
CGNT
|
994 M | $ 7.82 | - | $ 561 M | ||
|
Allied Healthcare Products
AHPI
|
696 K | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
5.82 M | - | -0.97 % | $ 54.4 M | ||
|
EDAP TMS S.A.
EDAP
|
252 M | $ 3.99 | - | $ 149 M | ||
|
AdaptHealth Corp.
AHCO
|
3.89 B | $ 9.4 | - | $ 1.27 B | ||
|
FONAR Corporation
FONR
|
91.5 M | $ 18.5 | -0.32 % | $ 121 M | ||
|
Apollo Endosurgery
APEN
|
423 M | - | - | $ 475 M | ||
|
CONMED Corporation
CNMD
|
2.57 B | $ 43.41 | - | $ 1.35 B | ||
|
Electromed
ELMD
|
170 M | $ 23.98 | - | $ 203 M | ||
|
CryoLife, Inc.
CRY
|
70.4 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
17.3 M | - | -20.74 % | $ 369 K | ||
|
CHF Solutions, Inc.
CHFS
|
-7.7 M | - | 1.15 % | $ 34.5 M | ||
|
AxoGen
AXGN
|
1.55 B | $ 29.83 | - | $ 1.37 B | ||
|
Apyx Medical Corporation
APYX
|
54.4 M | $ 3.17 | -3.35 % | $ 110 M | ||
|
InMode Ltd.
INMD
|
3.99 B | $ 13.6 | - | $ 879 M | ||
|
Axonics Modulation Technologies
AXNX
|
2.67 B | - | - | $ 3.31 B | ||
|
IRIDEX Corporation
IRIX
|
65.9 M | $ 1.43 | 1.42 % | $ 23.1 M | ||
|
IRadimed Corporation
IRMD
|
629 M | $ 104.29 | - | $ 1.32 B | ||
|
Soliton, Inc.
SOLY
|
-100 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.54 B | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
427 M | - | 0.03 % | $ 1.58 B | ||
|
Accuray Incorporated
ARAY
|
492 M | $ 0.53 | - | $ 54.5 M | ||
|
Misonix, Inc.
MSON
|
-1.79 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
639 M | - | - | $ 111 M | ||
|
Medigus Ltd.
MDGS
|
11.2 M | - | 10.28 % | $ 55.5 M | ||
|
LivaNova PLC
LIVN
|
4.58 B | $ 68.43 | -2.62 % | $ 3.73 B | ||
|
Pulmonx Corporation
LUNG
|
347 M | $ 1.53 | - | $ 59.8 M | ||
|
Cytosorbents Corporation
CTSO
|
87.4 M | $ 0.8 | 6.81 % | $ 43.5 M | ||
|
Align Technology
ALGN
|
15.2 B | $ 182.64 | - | $ 13.7 B | ||
|
Medtronic PLC
MDT
|
152 B | $ 96.71 | - | $ 124 B | ||
|
Intersect ENT, Inc.
XENT
|
1.02 B | - | - | $ 955 M | ||
|
Inari Medical
NARI
|
3.1 B | - | - | $ 4.23 B | ||
|
Butterfly Network
BFLY
|
765 M | $ 3.68 | - | $ 779 M | ||
|
BIOLASE
BIOL
|
26.8 M | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
187 B | $ 113.61 | - | $ 198 B | ||
|
NuVasive
NUVA
|
2.04 B | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
441 M | - | - | $ 217 M | ||
|
BioSig Technologies
BSGM
|
9.42 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
111 B | $ 73.85 | - | $ 109 B |